PEGASEMP™ – Nanoparticle patented in USA, in the media

The USA granted a patent to a new generation nanoparticle for the breast cancer treatment developed by a team of researchers from the Centre for Neuroscience and cell biology (CNC) and the Faculty of Pharmacy of the University of Coimbra.